Trials / Unknown
UnknownNCT05624866
Dexmedetomidine Versus Triamcinolone Treatment in Carpal Tunnel Syndrome
Dexmedetomidine Versus Triamcinolone Local Injection for Pain Alleviation in Patients With Carpal Tunnel Syndrome; A Randomized Clinical Trial.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Carpal tunnel syndrome (CTS) is a common mononeuropathy due to entrapment of the median nerve in the carpal tunnel. a lot of modalities are available for treatment of mild to moderate CTS.
Detailed description
Carpal tunnel syndrome (CTS) is a common mononeuropathy due to entrapment of the median nerve in the carpal tunnel. a lot of modaleties are available for treatment of mild to moderate CTS. In case of failed conservative oral therapey, local hydro-dessction of the median nerve can be done with saline alone. local anethetics, steroids, hyalase,and ozone have been utilized to augment the symptoms reliefe. Dexmeditomidine (DEX) has been studied as adjuvant for nerve block to aumnet the pain reliefe. Recently, it has been discovered that DEX can offer some antinflammatory effects when injected in the perineural area. Upon such discovery, the goal of this study has been built.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | injection of 1 microgram/kg dexmeditomidine + 10 cc saline injection nearby median nerve as hydro-dissection |
| DRUG | Triamcinolone | injection of 40 mg triamcinolone + 10 cc saline injection nearby median nerve as hydro-dissection |
Timeline
- Start date
- 2022-10-10
- Primary completion
- 2023-11-10
- Completion
- 2023-12-10
- First posted
- 2022-11-22
- Last updated
- 2023-10-31
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05624866. Inclusion in this directory is not an endorsement.